
<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:title>udk_1-11-1994_5-3-1994/0009.tif</dc:title>
  <dc:subject>drug approval</dc:subject>
  <dc:subject>HIV treatment</dc:subject>
  <dc:subject>criminal trials</dc:subject>
  <dc:subject>media coverage</dc:subject>
  <dc:subject>medical research</dc:subject>
  <dc:description>Bobbitt Trial Attracts Attention From Media and Special Groups -- Government Clears Drug for HIV-infected Patients to Aid in Preventing Pneumonia -- [advertisements]</dc:description>
  <dc:description>Descriptive metadata for this item has been generated in part using AI (artificial intelligence) technologies and may be incomplete, misleading, or inaccurate. Please contact the Kenneth Spencer Research Library with specific questions or concerns.</dc:description>
  <dc:description>Digitized from microfilm reel: NP 4734 (1994-01-11 to 1994-05-03)</dc:description>
  <dc:publisher>University Daily Kansan</dc:publisher>
  <dc:date>1994-01-11</dc:date>
  <dc:type>Text</dc:type>
  <dc:type>newspaper</dc:type>
  <dc:format>electronic</dc:format>
  <dc:format>image/tiff</dc:format>
  <dc:format>1 page</dc:format>
  <dc:identifier>ku-udk:130080</dc:identifier>
  <dc:identifier>https://digital.lib.ku.edu/ku-udk/130080</dc:identifier>
  <dc:rights>This Item may be protected by copyright and/or related rights. You are free to use this Item in any way that is permitted by the copyright and related rights legislation that applies to your use. For other uses you need to obtain permission from the rights-holder(s).</dc:rights>
</oai_dc:dc>